See also this year's filing and all EDGAR filings for this company.
PDF Report 0001813814_2022_Definium_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001813814, Definium Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 10,408,000 |
| 2 | remainder_Liabilities | 1,930,000 |
| 3 | AssetsCurrent | 137,215,000 |
| 4 | AssetsNoncurrent | 0 |
| 5 | PropertyPlantAndEquipmentNet | 0 |
| 6 | Goodwill | 19,918,000 |
| 7 | remainder_Assets | 6,869,000 |
| 8 | GeneralAndAdministrativeExpense | 59,065,000 |
| 9 | ResearchAndDevelopmentExpense | 34,789,000 |
| 10 | remainder_Expenses | -1,157,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -339,000 |
| 13 | remainder_ComprehensiveNetIncome | 762,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 12,338,000 |
| 1 | Assets | 164,002,000 |
| 2 | Expenses | 92,697,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 151,664,000 |
| 5 | NetIncome | -93,036,000 |
| 6 | ComprehensiveNetIncome | -92,655,000 |
| 7 | BaseVar | 135,069,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.31 |
| 9 | EconomicCapitalRatio | 1.89 |
Edgar->Model Mapping
Feature Distribution
